Toremifene |
Fareston |
Toremifene is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene is FDA approved for use in advanced (metastatic) breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene. Reference Price N, Sartor O, Hutson T, Mariani S. Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential che ...
Wikipedia - [full article]
Toremifene News Headlines
- Toremifene claimed to be useful in prostate cancer
The Earth Times - Mon, 26 Feb 2007 10:41 EST
- GTx's Phase III Clinical Development Of ACAPODENE On Course Following Planned Safety Review
MedicalNewsToday - Wed, 06 Sep 2006 07:00 EST
- In A Phase III Lipid Interim Analysis, ACAPODENE Treatment Lowered Cholesterol And Raised HDL In Prostate Cancer Patients On Androgen Deprivation
MedicalNewsToday - Fri, 23 Jun 2006 06:00 EST
- New drug relieves premenstrual breast pain
Reuters - Tue, 13 Jun 2006 03:38 EST

Not Signed In -


